Patient Services

David C. Koch Regional Perfusion Cancer Therapy Center

The David C. Koch Regional Cancer Therapy Center currently treats cancers with several forms of HIPEC:

Intraperitoneal Hyperthermic Chemotherapy is used to treat cancers of the abdomen and chest, including:

Peritoneal Carcinomatosis
- Appendiceal Primary
- Colon Primary
- Ovarian Primary (in rare cases)
Adenomucinosis
Primary Serous Adenocarcinoma of the Peritoneum
Mesothelioma - peritoneal or pleural
Pseudomyxoma Peritoneii
Peritoneal Sarcomatosis

Regional Liver Perfusion is used to treat non-primary hepatic cancers, including:

Colon cancer that has metastacized to the liver
Liver metastasis from other primary cancers

Limb Perfusion is used to treat:

Malignant melanoma of an extremity

These techniques have been well established from a technical perspective, and success against cancer has been demonstrated. Isolated liver perfusion has been associated with a 74-percent response rate and 27-month median survival in patients with unresectable colorectal metastases. A randomized trial has demonstrated a 10-month improvement in median survival in patients treated with intraperitoneal hyperthermic chemoperfusion for peritoneal carcinomatosis from colon cancer. Isolated limb perfusion is associated with a 78 to 100 percent overall response rate in patients with advanced melanoma.